Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma

NCT07282587 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.

NCT NCT07282587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07282587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of ONC206 in Advanced Pheochromocytoma and Paraganglioma
Lead sponsor
Jazz Pharmaceuticals
Phase
Phase 2
Overall status
Recruiting
Start date
January 2, 2026
Completion date
December 15, 2028
Enrollment
90 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pheochromocytoma and paraganglioma, pcpg